Covance launches COVID-19 clinical trial matching platform
The drug development firm has introduced COVID-19 Clinical Trial Connect, a site designed to help potential patients match with research studies.
Covance, the drug development...
Johnson & Johnson moves up COVID-19 vaccine trial to second half of July
Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of...
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment...
Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients
Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19....
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial
FSD Pharma Inc. received approval from the U.S. FDA to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide,...
Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients
Sun Pharmaceutical Industries Ltd. has announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial...
AbCellera’s Rapid Pandemic Response Platform Contributes to the World’s First COVID-19 Clinical Trial for a Potential Monoclonal Antibody Treatment
AbCellera announced that LY-CoV555, the lead antibody from the collaboration between AbCellera and Eli Lilly and Company (Lilly), has entered into human testing for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...